Literature DB >> 32444061

Evidence Base of Clinical Studies on Qi Gong: A Bibliometric Analysis.

Ya-Peng Zhang1, Rui-Xue Hu2, Mei Han3, Bao-Yong Lai4, Shi-Bing Liang5, Bing-Jie Chen6, Nicola Robinson7, Kevin Chen8, Jian-Ping Liu9.   

Abstract

OBJECTIVE: This bibliometric study aimed to systematically and comprehensively summarize the volume, breadth and evidence for clinical research on Qigong. And this bibliometric analysis also can provide the evidence of this field.
DESIGN: Bibliometric analysis.
METHODS: All types of primary and secondary studies on humans were included: systematic reviews, randomized clinical trials, non-randomized controlled clinical studies, case series and case reports. Chinese Biomedical Literature Database, China National Knowledge Infrastructure, Chinese Scientific Journal Database, Chinese Academic Conference Papers Database and Chinese Dissertation Database, PubMed and the Cochrane Library were searched from the date of inception to December 10, 2018. Bibliometric information, such as publication information, disease/condition, Qigong intervention and research results were extracted and analyzed.
RESULTS: A total of 886 clinical studies were identified: including 47 systematic reviews, 705 randomized clinical trials, 116 non-randomized controlled clinical studies, 12 case series and 6 case reports. The studies were conducted in 14 countries. The top 15 diseases/conditions studied were: diabetes, chronic obstructive pulmonary disease, hypertension, stroke, cervical spondylosis, lumbar disc herniation, insomnia, knee osteoarthritis, low back pain, and osteoporosis, Coronary heart disease, breast cancer, periarthritis of shoulder, depression, metabolic syndrome. Of the various Qigong exercises reported in these 886 clinical studies, Ba Duan Jin was the most frequently researched in 492 (55.5%) studies, followed by Health Qigong 107 (12.1%), Dao Yin Shu 85 (9.6%), Wu Qin Xi 67 (7.6%) and Yi Jin Jing 66 (7.4%). The most frequently used comparisons in randomized trials were maintaining normal way of life unchanged 149 (18.1%), the remaining controls included conventional treatment, mainly western medicine, Chinese herbal medicine, acupuncture, health education, psychological therapy, Yoga, Tai Chi and other non-drug therapy. The most frequently reported outcomes were physical function, quality of life, symptoms, pain and mental health indicators. Beneficial results from practicing Qigong were reported in 97% of studies.
CONCLUSIONS: Qigong research publications have been increasing gradually. Reports on study types, participants, Qigong Intervention, and outcomes are diverse and inconsistent. There is an urgent need to develop a set of reporting standards for various interventions of Qigong. Further trials of high methodological quality with sufficient sample size and real world studies are needed to verify the effects of Qigong in health and disease management.
Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Ba Duan Jin; Bibliometric Analysis; Clinical Study; Non-drug therapy; Qigong

Year:  2020        PMID: 32444061     DOI: 10.1016/j.ctim.2020.102392

Source DB:  PubMed          Journal:  Complement Ther Med        ISSN: 0965-2299            Impact factor:   2.446


  13 in total

Review 1.  Exercise-based cardiac rehabilitation for coronary heart disease.

Authors:  Grace Dibben; James Faulkner; Neil Oldridge; Karen Rees; David R Thompson; Ann-Dorthe Zwisler; Rod S Taylor
Journal:  Cochrane Database Syst Rev       Date:  2021-11-06

Review 2.  Bibliometric and Visualized Analysis of 2011-2020 Publications on Physical Activity Therapy for Diabetes.

Authors:  Keke Huang; Jing Zhu; Shaozhe Xu; Rong Zhu; Xi Chen
Journal:  Front Med (Lausanne)       Date:  2022-04-07

3.  Menopausal osteoporosis: screening, prevention and treatment.

Authors:  Eu-Leong Yong; Susan Logan
Journal:  Singapore Med J       Date:  2021-04       Impact factor: 1.858

4.  The effectiveness of Baduanjin exercise for hypertension: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Bao-Yi Shao; Xia-Tian Zhang; Robin W M Vernooij; Qiu-Yi Lv; Yao-Yang Hou; Qi Bao; Li-Xing Lao; Jian-Ping Liu; Ying Zhang; Gordon H Guyatt
Journal:  BMC Complement Med Ther       Date:  2020-10-08

5.  WeChat as a Platform for Baduanjin Intervention in Patients With Stable Chronic Obstructive Pulmonary Disease in China: Retrospective Randomized Controlled Trial.

Authors:  Junjie Bi; Wei Yang; Ping Hao; Wei Zhang; Xiongbiao Wang; Yongmei Zhao; Dan Wei; Yipeng Sun; Yuhua Lin; Meng Sun; Xuan Chen; Xuming Luo; Shanqun Li
Journal:  JMIR Mhealth Uhealth       Date:  2021-02-02       Impact factor: 4.773

6.  Bibliometric Analysis Reveals a 20-Year Research Trend for Chemotherapy-Induced Peripheral Neuropathy.

Authors:  Jialin Gu; Miao Hu; Zhancheng Gu; Jialin Yu; Yi Ji; Lingchang Li; Canhong Hu; Guoli Wei; Jiege Huo
Journal:  Front Neurol       Date:  2022-02-08       Impact factor: 4.003

7.  The Impact of Qigong and Tai Chi Exercise on Drug Addiction: A Systematic Review and Meta-Analysis.

Authors:  Jiabao Cui; Fang Liu; Xuan Liu; Ru Li; Xiaorong Chen; Hongfa Zeng
Journal:  Front Psychiatry       Date:  2022-03-08       Impact factor: 4.157

8.  The Effectiveness of Traditional Chinese Yijinjing Qigong Exercise for the Patients With Knee Osteoarthritis on the Pain, Dysfunction, and Mood Disorder: A Pilot Randomized Controlled Trial.

Authors:  Shuaipan Zhang; Guangxin Guo; Xing Li; Fei Yao; Zhiwei Wu; Qingguang Zhu; Min Fang
Journal:  Front Med (Lausanne)       Date:  2022-01-11

9.  Insight into the characteristics of research published in traditional, complementary, alternative, and integrative medicine journals: a bibliometric analysis.

Authors:  Jeremy Y Ng
Journal:  BMC Complement Med Ther       Date:  2021-07-01

Review 10.  Aristolochic acid nephropathy: A scientometric analysis of literature published from 1971 to 2019.

Authors:  Hongjian Ji; Jingyin Hu; Guozhe Zhang; Jianxiang Song; Xiaohua Zhou; Dean Guo
Journal:  Medicine (Baltimore)       Date:  2021-07-09       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.